InnovAge Holding Corp. Net Income
InnovAge Holding Corp. (INNV) reported Net Income of -$2.54 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-09-09
- InnovAge Holding Corp. net income (loss) attributable to parent for the quarter ending 2026-06-30 was $8.29M.
- InnovAge Holding Corp. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$29.46M.
- InnovAge Holding Corp. net income (loss) attributable to parent for the quarter ending 2025-12-31 was $10.62M.
- InnovAge Holding Corp. net income (loss) attributable to parent for the quarter ending 2025-09-30 was $8.02M.
- InnovAge Holding Corp. net income (loss) attributable to parent for fiscal 2026 was -$2.54M.
- InnovAge Holding Corp. net income (loss) attributable to parent for fiscal 2025 was -$30.31M.
- InnovAge Holding Corp. net income (loss) attributable to parent for fiscal 2024 was -$21.34M.
- InnovAge Holding Corp. net income (loss) attributable to parent for fiscal 2023 was -$40.67M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$21.17M derived: sum of 2 quarters · filed 2026-09-09 | -$10.56M derived: sum of 3 quarters · filed 2026-09-09 | -$2.54M 10-K · filed 2026-09-09 |
| 2026-03-31 | -$29.46M 10-Q · filed 2026-05-08 | -$18.84M derived: sum of 2 quarters · filed 2026-05-08 | -$10.82M 10-Q · filed 2026-05-08 | -$11.61M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $10.62M 10-Q · filed 2026-02-03 | $18.64M 10-Q · filed 2026-02-03 | $17.85M derived: sum of 3 quarters · filed 2026-09-09 | $6.47M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $8.02M 10-Q · filed 2025-11-04 | $7.23M derived: sum of 2 quarters · filed 2026-09-09 | -$4.14M derived: sum of 3 quarters · filed 2026-09-09 | -$17.36M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | -$785.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$12.16M derived: sum of 2 quarters · filed 2026-09-09 | -$25.38M derived: sum of 3 quarters · filed 2026-09-09 | -$30.31M 10-K · filed 2026-09-09 |
| 2025-03-31 | -$11.38M 10-Q · filed 2026-05-08 | -$24.60M derived: sum of 2 quarters · filed 2026-05-08 | -$29.53M 10-Q · filed 2026-05-08 | -$31.23M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$13.22M 10-Q · filed 2026-02-03 | -$18.15M 10-Q · filed 2026-02-03 | -$19.85M derived: sum of 3 quarters · filed 2026-02-03 | -$25.74M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$4.93M 10-Q · filed 2025-11-04 | -$6.63M derived: sum of 2 quarters · filed 2025-11-04 | -$12.52M derived: sum of 3 quarters · filed 2025-11-04 | -$15.96M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | -$7.59M derived: sum of 2 quarters · filed 2025-09-09 | -$11.03M derived: sum of 3 quarters · filed 2025-09-09 | -$21.34M 10-K · filed 2025-09-09 |
| 2024-03-31 | -$5.89M 10-Q · filed 2025-05-06 | -$9.33M derived: sum of 2 quarters · filed 2025-05-06 | -$19.64M 10-Q · filed 2025-05-06 | -$30.82M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$3.45M 10-Q · filed 2025-02-04 | -$13.75M 10-Q · filed 2025-02-04 | -$24.93M derived: sum of 3 quarters · filed 2025-02-04 | -$31.56M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | -$10.30M 10-Q · filed 2024-11-05 | -$21.48M derived: sum of 2 quarters · filed 2024-11-05 | -$28.11M derived: sum of 3 quarters · filed 2024-11-05 | -$37.90M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$11.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | -$17.81M derived: sum of 2 quarters · filed 2024-09-10 | -$27.60M derived: sum of 3 quarters · filed 2024-09-10 | -$40.67M 10-K · filed 2024-09-10 |
| 2023-03-31 | -$6.63M 10-Q · filed 2024-05-07 | -$16.42M derived: sum of 2 quarters · filed 2024-05-07 | -$29.50M 10-Q · filed 2024-05-07 | -$42.20M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$9.79M 10-Q · filed 2024-02-06 | -$22.87M 10-Q · filed 2024-02-06 | -$35.58M derived: sum of 3 quarters · filed 2024-02-06 | -$38.40M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | -$13.07M 10-Q · filed 2023-11-07 | -$25.78M derived: sum of 2 quarters · filed 2023-11-07 | -$28.60M derived: sum of 3 quarters · filed 2023-11-07 | -$27.28M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$12.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | -$15.53M derived: sum of 2 quarters · filed 2023-09-12 | -$14.21M derived: sum of 3 quarters · filed 2023-09-12 | -$6.52M 10-K · filed 2023-09-12 |
| 2022-03-31 | -$2.82M 10-Q · filed 2023-05-09 | -$1.50M derived: sum of 2 quarters · filed 2023-05-09 | $6.19M 10-Q · filed 2023-05-09 | $12.66M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.32M 10-Q · filed 2023-02-07 | $9.01M 10-Q · filed 2023-02-07 | $15.48M derived: sum of 3 quarters · filed 2023-02-07 | $4.97M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | $7.69M 10-Q · filed 2022-11-08 | $14.16M derived: sum of 2 quarters · filed 2022-11-08 | $3.65M derived: sum of 3 quarters · filed 2022-11-08 | $13.36M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $6.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | -$4.04M derived: sum of 2 quarters · filed 2022-09-13 | $5.67M derived: sum of 3 quarters · filed 2022-09-13 | -$43.99M 10-K · filed 2022-09-13 |
| 2021-03-31 | -$10.51M 10-Q · filed 2022-05-10 | -$805.00K derived: sum of 2 quarters · filed 2022-05-10 | -$50.46M 10-Q · filed 2022-05-10 | -$38.36M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $9.71M 10-Q · filed 2022-02-09 | -$39.95M 10-Q · filed 2022-02-09 | -$27.85M derived: sum of 3 quarters · filed 2022-02-09 | -$19.71M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-09-30 | -$49.65M 10-Q · filed 2021-11-09 | -$37.56M derived: sum of 2 quarters · filed 2021-11-09 | -$29.42M derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $20.23M derived: sum of 2 quarters · filed 2021-09-23 | $26.28M 10-K · filed 2021-09-23 | |
| 2020-03-31 | $8.14M 10-Q · filed 2021-05-11 | $14.18M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |